https://www.statnews.com/2026/03/25/merck-terns-pharmaceuticals-leukemia-tern701/
Merck to buy Terns Pharmaceuticals in $6.7B deal
Mar 25, 2026 - The deal's centerpiece is a promising leukemia drug, which could help Merck offset the impending decline of Keytruda revenue.
merckbuyternspharmaceuticalsdeal
https://www.theverge.com/2024/6/25/24185941/lan-terns-lan-terns-whatcha-gonna-do
Lan-terns Lan-terns, whatcha gonna do? | The Verge
the vergelanternsgonna
https://www.statnews.com/2026/04/08/biotech-news-terns-drug-may-not-be-as-competitive-as-initially-believed/
Terns, Merck, Gilead, Tubulis: Readout Newsletter
ternsmercknewsletter
https://www.ternspharma.com/
Home - Terns Pharma
Oct 30, 2025 - Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious...
ternspharma
https://www.statnews.com/2025/12/08/ash-positive-results-leukemia-terns-rival-novartis/
At ASH, positive news for Terns, Kura leukemia treatments | STAT
Dec 8, 2025 - The ASH meeting included positive early results about a Terns drug for chronic myeloid leukemia and a Kura menin-blocker for acute myeloid leukemia.
positive newsashternskuraleukemia